Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells

Molecular Pharmaceutics

Volumn 6, Issue 5, 2009, Pages 1380-1387

  Chorny, Michael ^a   Fishbein, Ilia ^a   Alferiev, Ivan ^a   Levy, Robert J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Adenoviral gene delivery; Affinity complexation; Magnetic nanoparticle; Magnetically enhanced gene transfer; Particle virus hybrid system

Indexed keywords

ADENOVIRUS VECTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; NANOPARTICLE; POLYLACTIDE;

ANIMAL CELL; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL GROWTH; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUOROMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAGNETICALLY ENHANCED GENE TRANSFER; MULTIPLE REGRESSION; NONHUMAN; PRIORITY JOURNAL; RAT; SAFETY; SMOOTH MUSCLE FIBER; VIRAL GENE DELIVERY SYSTEM; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; FLUORESCENT DYES; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE, SMOOTH; NANOTECHNOLOGY; RATS; RECEPTORS, VIRUS; RECOMBINANT PROTEINS;

EID: 70350055334     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp900017m     Document Type: Conference Paper

References (26)

1. Palmer, D.; Ng, P. Improved system for helper-dependent adenoviral vector production. Mol. Ther. 2003, 8, 846-852 (Pubitemid 37527461)
2. Othman, M.; Labelle, A.; Mazzetti, I.; Elbatarny, H. S.; Lillicrap, D. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood 2007, 109 (7), 2832-2839 (Pubitemid 46482078)
3. Morral, N.; O'Neal, W.; Zhou, H.; Langston, C.; Beaudet, A. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum. Gene Ther. 1997, 8 (10), 1275-1286 (Pubitemid 27394135)
4. Tripathy, S. K.; Black, H. B.; Goldwasser, E.; Leiden, J. M. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 1996, 2, 545-550 (Pubitemid 26150681)
5. Schnell, M. A.; Zhang, Y.; Tazelaar, J.; Gao, G. P.; Yu, Q. C.; Qian, R.; Chen, S. J.; Varnavski, A. N.; LeClair, C.; Raper, S. E.; Wilson, J. M. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol. Ther. 2001, 3 (5 Part 1), 708-722
6. Raper, S. E.; Chirmule, N.; Lee, F. S.; Wivel, N. A.; Bagg, A.; Gao, G. P.; Wilson, J. M.; Batshaw, M. L. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 2003, 80, 148-158
7. Marshall, E. Gene therapy death prompts review of adenovirus vector. Science 1999, 286, 2244-2245 (Pubitemid 30016842)
8. Mizuguchi, H.; Hayakawa, T. Targeted adenovirus vectors. Hum. Gene Ther. 2004, 15, 1034-1044
9. Parker, A. L.; Nicklin, S. A.; Baker, A. H. Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications. Curr. Opin. Mol. Ther. 2008, 10, 439-448
10. Carson, S. D. Receptor for the group B coxsackieviruses and adenoviruses: CAR. Rev. Med. Virol. 2001, 11, 219-226
11. Chorny, M.; Fishbein, I.; Alferiev, I. S.; Nyanguile, O.; Gaster, R.; Levy, R. J. Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression. Mol. Ther. 2006, 14, 382-391
12. Pandori, M.; Hobson, D.; Sano, T. Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery. Virology 2002, 299, 204-212 (Pubitemid 35356597)
13. Chorny, M.; Polyak, B.; Alferiev, I. S.; Walsh, K.; Friedman, G.; Levy, R. J. Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles. FASEB J. 2007, 21, 2510-2519 (Pubitemid 47230680)
14. Nyanguile, O.; Dancik, C.; Blakemore, J.; Mulgrew, K.; Kaleko, M.; Stevenson, S. C. Synthesis of adenoviral targeting molecules by intein-mediated protein ligation. Gene Ther. 2003, 10, 1362-1369
15. O'Brien, J.; Wilson, I.; Orton, T.; Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000, 267, 5421-5426 (Pubitemid 30679258)
16. Marquardt, D. W. An Algorithm for Least Squares Estimation of Nonlinear Parameters. J. Soc. Ind. Appl. Math. 1963, 11, 431-441
17. Polyak, B.; Fishbein, I.; Chorny, M.; Alferiev, I.; Williams, D.; Yellen, B.; Friedman, G.; Levy, R. J. High field magnetic gradients can target magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 698-703.
18. Mok, H.; Park, J. W.; Park, T. G. Microencapsulation of PEGylated adenovirus within PLGA microspheres for enhanced stability and gene transfection efficiency. Pharm. Res. 2007, 24, 2263-2269
19. Turner, P.; Petch, A.; Al-Rubeai, M. Encapsulation of viral vectors for gene therapy applications. Biotechnol. Prog. 2007, 23, 423-429 (Pubitemid 46626317)
20. Mah, C.; Fraites, T. J., Jr.; Zolotukhin, I.; Song, S.; Flotte, T. R.; Dobson, J.; Batich, C.; Byrne, B. J. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. Mol. Ther. 2002, 6, 106-112 (Pubitemid 36124277)
21. Yellen, B. B.; Forbes, Z. G.; Halverson, D. S.; Fridman, G.; Barbee, K. A.; Chorny, M.; Levy, R.; Friedman, G. Targeted drug delivery to magnetic implants for therapeutic applications. J. Magn. Magn. Mater. 2005, 293, 647-654 (Pubitemid 40608991)
22. Yellen, B. B.; Chorny, M.; Fishbein, I.; Dai, N.; Ottey, A.; Klingerman, C.; Alferiev, I.; Nyanguile, O.; Friedman, G.; Levy, R. J. Site specific gene delivery using magnetic forces to localize adenoviral vector-magnetic nanoparticle complexes to stented arterial segments. Circulation 2005, 112 17 (Suppl. II), 653.
23. Molpeceres, J.; Guzman, M.; Aberturas, M. R.; Chacón, M.; Berges, L. Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement. J. Pharm. Sci. 1996, 85, 206-213 (Pubitemid 26055803)
24. Wehrle, P.; Magenheim, B.; Benita, S. The influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design. Eur. J. Pharm. Biopharm. 1995, 41, 19-26.
25. Attivi, D.; Wehrle, P.; Ubrich, N.; Damge, C.; Hoffman, M.; Maincent, P. Formulation of insulin-loaded polymeric nanoparticles using response surface methodology. Drug Dev. Ind. Pharm. 2005, 31, 179-189 (Pubitemid 40315713)
26. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 2001, 53, 283-318.